GE, Shine successfully create medical isotope Tc-99m

By staff writers

November 9, 2015 -- GE Healthcare and Shine Medical Technologies have successfully obtained pharmaceutical-grade technetium-99m (Tc-99m) from GE's Drytec (Tc-99m generator) using molybdenum-99 (Mo-99) produced by Shine.

The positive results confirm that the Mo-99 produced by the Shine process can be incorporated into the existing Mo-99 supply chain. Once approved by the U.S. Food and Drug Administration (FDA), the use of Shine-produced Mo-99 in Drytec will not require changes to radiopharmacy practices or how the resulting Tc-99m is used in scanning procedures, the firms said.

Shine is expected to begin commercial production in 2019 using this new process, and it expects to be able to produce enough Mo-99 to supply two-thirds of the U.S. patient population.

Copyright © 2015

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking